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Abstract
According to the World Health Organisation (WHO), deaths from non-communicable diseases (NCDs) will increase
globally, with the largest increase being on the African continent. On our continent, projections have indicated that
deaths from NCDs will exceed all combined communicable, maternal, perinatal and nutritional diseases as the most
common causes of death by 2030. Hence, the importance of a functional and improved pathology system in the
diagnosis of cancer cannot be debated.
Recently, the African Organization for Research and Training in Cancer (AORTIC) organised its East African regional
meeting in Mwanza, Tanzania on 25–26 June 2015, with the focus being ‘Pathology and oncology: Education and
training for the future in cancer research’. The main themes of the workshop were around improving cancer care
and the role of twinning in Eastern Africa, in particular the Mwanza cancer project, telepathology, e-health and
biobanking. The outcomes of a 2 day strategic meeting were developing an efficient and effective plan to guide
the improvement in pathology training and cancer research in Africa.
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Introduction
Africa is a continent of opportunities for growth. It is a
continent undergoing a rapid economic transformation,
which, however, will result in an increase of non-
communicable diseases (NCDs). Estimates suggest that
the annual number of new cases over the next 5 years
will grow to above 1 million. Predicted deaths from
NCDs over the next 10 years will also increase globally
by 17 %, the greatest increase being in Africa (27 % or
28 million deaths) [1].
The importance of pathology in correct diagnostics
and further adequate cancer treatments cannot be em-
phasized enough. There are currently still a high number
of African countries in which pathology services are
struggling with a limited number of pathologists,
inadequate infrastructure and with severely restricted
budgets from the government. At the same time, path-
ology is unarguably the backbone of the success of the
cancer care.
In June 2015, AORTIC (African Organization for Re-
search and Training in Cancer) organised its East African
regional meeting in Mwanza, Tanzania on 25–26 June
2015, with the focus being ‘Pathology and oncology:
Education and training for the future in cancer re-
search’. This meeting is the first in a series of regional
meetings expected to follow the African Pathologist’
Summit organised by Aortic in Dakar, Senegal in 2013.
The emphasis of the meeting was on explorating re-
gional resources, including professional and technical
manpower that will be critical for improving pathology
diagnostics, clinical oncology, research, as well as educa-
tion and training in the region. In the past, there has
been a lot of talk about the role of African pathology in
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the context of clinical oncology, often with very limited
follow up and action.
The meeting was a strategic meeting attended by 26 par-
ticipants coming from 21 institutions and 8 countries.
This meeting produced a list of initiatives that resulted
in a joint collaboration within East Africa, integrating
pathology, clinical oncology, education and training, and
research, bringing together scientists, governments, dias-
pora and international organizations.
The role of pathology in cancer care
After a short introduction by the vice-president of Aor-
tic Eastern Africa, Louis Ngendahayo, pathologist from
Burundi, a welcome address by the local organiser
Nestory Masalu, and an opening address by the secretary
treasurer elect Nicholas Othieno-Abinya, the first talk
was given by the chair of the Aortic pathology group,
Adesina Adenkule. The chair talked about the role of
pathology in cancer care and interacted with the audi-
ence, raising the question of meeting the needs of this
issue in Africa.
The challenges facing pathology diagnostics, education
and oncology research in Africa, and specifically in East
Africa, are multiple and daunting. They include, inter
alia, (i) the lack of or inadequate infrastructure, (ii) inad-
equate personnel: both pathologists and technical
personnel, (iii) inadequacy of opportunities for profes-
sional education or training, (iv) ‘brain drain’ following
many years of political military taking over with mis-
management of the health-care services and (v) a lack of
or insufficient funding for basic laboratory materials
such as reagents.
While we acknowledge these challenges, many of
which are not going to go away in the foreseeable future,
custodians of African and specifically East African path-
ology and clinical oncology must begin to ask new and
pragmatic questions, for example: How can we deliver a
better and more acceptable quality of services within the
limits of current resources? The ‘game plan’ must ad-
dress the following, immediately and in a sustained way.
It must:
 explore avenues for updating the knowledge base of
practicing pathologists in a sustainable way,
addressing the processes for enhancing the quality of
training of current pathology trainees and technical
staff
 explore the need for continuous quality
improvement and quality assurance
 develop training in appropriate new technologies
when relevant to the level of practice
 address the need for advocacy to both private
funding agencies (local and international) and
government/ministries of health.
In executing this game plan, urgent attention must be
given to database development to provide information
on current status and ongoing activities as we move to-
wards measuring success versus failure. In addition,
there must be an emphasis on education and training. It
is crucial to define short-term (immediate deliverables)
and long-term educational goals. Pathology education
will most likely yield early dividends in improved patient
care and outcomes. However, long-term dividends will
only come with the development of local advocacy and
subsequent improvement of infrastructure.
‘Cancer in Africa: what needs to be done?’
The keynote address was given by Twalib Ngoma, previ-
ous Aortic president, who underlined that cancer is
often not seen as a priority in many African countries.
Out of the 6 % of the gross national expenditure that is
spent on health care in Tanzania, less than 0.1 % of
available resources for health services are allocated for
such services in the oncology field, even though 8–10 %
of the disease burden in Africa is due to cancer.
The present situation in Africa is dominated by a low
cancer awareness, inexistent or inefficient cancer pre-
vention, overburdened health systems, and inadequately
funded and structurally challenged health systems to
meet the expected doubling of the number of cancer
patients in the next 15–20 years.
A situation like this needs to be remedied urgently by
changing the mind-set of Africans about cancer, under-
standing the magnitude of the problem of cancer in
Africa and formulating realistic implementable National
Cancer Control Plans (NCCP).
The availability of cancer registries, which have accur-
ate information and data on the national and local situ-
ation, is crucial for the planning, implementing and
evaluating the NCCP.
The lecture was followed by a discussion group led by
three panellists who represented local pathologists from
Tanzania, Uganda and Kenya. The panellists led a dis-
cussion on defining practice pathology goals in the East
African resource-poor environment to a high standard.
The second part of the first day was dedicated to the
role of telemedicine, telepathology, e-health for clinical
oncology and a practical demonstration of digital path-
ology. The demonstration took place at Bugando Med-
ical Centre Mwanza, Tanzania.
Cancer control project and intervention model in the
Mwanza region
Until 2009 in Tanzania, an African country with a popu-
lation of over 50 million inhabitants, only one hospital
(Ocean Road Cancer Institute in Dar El Salam) offered
systematic cancer treatment.
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The Mwanza Cancer Project, the idea of the Vittorio
Tison Association in Italy, in collaboration with the gov-
ernment of Tanzania gave rise to the second centre situ-
ated in the north-west part of the country. The evolution
of this project was co-presented by Dino Amadori and
Nestory Masalu This was a comprehensive cancer centre
dedicated to cancer care and control, covering all the is-
sues related to cancer, from community awareness and
education through early detection and treatment, to pallia-
tive care and surgery, based on a structured cancer
programme.
The cancer control project is structured into four
main intervention areas: prevention and early diagnosis,
assistance and therapy, education, and research.
Anatomic pathology laboratory
The establishment of the histopathology laboratory
started in 2000, with the Italians sponsoring the training
of a pathologist, a medical oncologist and four oncology
nurses. Soon after that, Bugando Medical Centre became
a specialised hospital in north-west Tanzania. The hos-
pital has 850-bed capacity for a catchment population of
16 million, equivalent to one-third of the population of
Tanzania.
The histopathology laboratory, which currently has
two pathologists, has the capacity to perform 4 000
histological analyses and 1 000 cytologies per year. The
technical diagnostic activity of the laboratory is sup-
ported by a local professional team, and by Italian volun-
teer pathologists and technicians that periodically work
in this structure. The Association continues to offer sup-
port for both diagnostic activity management and new
technology development.
Medical oncology unit
Shortly after the opening of the laboratory, an oncology
department was created, initially receiving a total of 40
beds. In the past 4 years, the department has experi-
enced a 10-fold growth in the number of patients, which
has increased from 300 new cases in 2010 to more than
3 000 in 2014.
As patients tend to present with the advanced disease,
there is a great need for a palliation centre. This special-
ized service has been integrated into the existing home-
based care programme for patients with HIV/AIDS. An-
nually, approximately 300 patients with advanced disease
make use of the facility’s services, while double this
number are under community-based care.
In the last few years, the focus was on prevention with
the introduction of a screening programme which has
been initiated for breast and cervical cancer with more
than 4 000 women enrolled in the last 3 years.
Medicines supply
The Association, in collaboration with IRST, is respon-
sible for the supply of drugs which are unavailable in the
country, in order to guarantee the best therapeutic qual-
ity and continuity of treatment to cancer patients.
Radiotherapy
The Association donated a linear accelerator. The ac-
complishment of establishing a high-level radiotherapy
facility in a geographical area that is completely under-
served in this field, represents a fundamental improve-
ment of the quality of cancer therapy in that country.
Education
The Association supports permanent educational and
professional training programmes for the Bugando Med-
ical Center health-care assistants through residential in-
ternships in oncological structures, specific educational
events, academic specialisation courses and 1st and 2nd
level master’s degrees.
Research
Research is a strategic area in order to provide high level
assistance in oncology. On the initiative of Vittorio
Tison Association, in August 2012, AFRICOG (African
Italian Cooperative Oncology Group) was founded with
the purpose of developing clinical and epidemiological
research activities among the sub-Saharan population.
X Vittorio Tison Association “Culture & Solidarity” ONLUS
Founded in 1999 the association aims to promote cul-
tural and scientific initiatives, both in Italy and abroad,
on issues of human solidarity, in particular in the field of
health and social care in oncology.
Telepathology and application in pathology diagnostics
The next presentation was given by Matteo Botteghi
who described telepathology, and the basics and applica-
tion in pathology diagnostics.
He underlined that the incidence of pathologies like
tumors and infections in developing countries is dramat-
ically increasing, currently representing a significant
public health burden. The ability to provide early diag-
nosis, treatments, and follow-up care has a large impact
on care efficacy and patient survival.
Telemedicine is defined as the delivery of health-care
services in areas where distance is a critical factor, for all
health-care professionals by using information and com-
munication technologies (ICT) to exchange valid infor-
mation for diagnosis, treatment and prevention of
disease and injuries, research and evaluation, and for the
continuing education of health-care providers, all in the
interests of advancing the health of individuals and their
communities.
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Although telemedicine implementation largely remains
a privilege of developed countries with more economic
resources, it could be of great use and efficacy in devel-
oping countries that lack appropriate health-care facil-
ities by encouraging good health-care practices.
The World Wide Web and ICT play a pivotal role in
telemedicine diffusion. ‘Digital Divide’ is a term that de-
scribes the economic and social inequality of access, use
and knowledge of the Internet and ICT. Telemedicine
has the potential to be used in many services and appli-
cations such as Voice over IP telephony, web conferen-
cing, teleconsulting, medical records software, remote
digital imaging, e-learning, video broadcasting, robotic
remotized systems, remote surgery, home-care solutions,
e-Hospital, and several others. Service and equipment
are divided into categories: Network Critical Physical In-
frastructures (NCPI), network connectivity (Internet and
other networks), network devices, ICT applications, elec-
tromedical devices, and private and public hosted
services.
In low-income countries, cost and the availability of
Internet connections are limiting factors to the diffusion
of telemedicine. In sub-Saharan Africa, there are a lim-
ited number of low-cost telemedicine solutions available,
for example, using long wireless links to carry clinical
data and remote counseling.
In the field of telepathology, the Italian NGO, Patholo-
gists Beyond Borders, has 20 years of experience, in sev-
eral African countries, of implementing satellite data
transfer in very poor and disadvantaged situations, in
order to perform remote diagnosis. The large number of
pending open issues tells us that we now need a more
adequate and modern approach to deal with telemedi-
cine requirements.
Matteo’s presentation also described the telemedicine
project between Istituto Scientifico Romagnolo per lo
Studio e la Cura dei Tumori (IRST) in Meldola (Italy)
(IRST), Italy, and the Bugando Medical Centre Mwanza,
Tanzania, initiated in 2012: the ‘Share & Mee’ telemedi-
cine project. Share & Meet includes a novel telematics
platform, which is oriented to oncology and its related
branches. The project is developed with cooperative pro-
grammes, including training medical staff, remote path-
ology diagnosis and other e-oncology applications.
The value of e-health in clinical oncology
One of the panellists, Wil Ngwa (part of the African dias-
pora), presented the value that e- health has for clinical
oncology. According to the World Health Organization, e-
health is defined “as the transfer of health resources and
health care by electronic means. It involves delivery of
health information for health professionals and consumers
via information and communication technologies (ICTs)
e.g. the Internet and mobile phones. It also includes using
the power of ICTs to improve public health services, e.g.
through the education and training of health workers and
related research. ”
There is a growing consensus that ICTs have tremen-
dous potential to catalyse global health collaborations.
Advanced ICTs can be employed to elide space-time
limitations to leverage a major recent upsurge in global
health interest into greater space-time flexible collabora-
tive action against cancer. There are currently a number
of emerging models for e-health collaborations in clinical
oncology that harness the power of ICTs. The Global
Health Catalyst (GHC) programme at the Dana Farber/
Harvard Cancer Center (DF/HCC) represents one such
model aimed at making it easier for anyone interested in
e-health to participate, promoting knowledge-sharing, and
helping to scale-up or expand successful clinical oncology
e-health models in cancer care, research and education.
There is a plan to roll out a number of initiatives that will
directly benefit e-health for clinical oncology in Africa.
More specifically, in clinical oncology, some e-health
models include tumor boards, remote consultation sup-
port via phone or the Internet, remote treatment planning
and quality assurance. These are all models that can be
scaled or extended to benefit many African country insti-
tutions in a lower-cost approach to help eliminate prevail-
ing disparities in clinical oncology. Meanwhile, under
education, online learning represents the future. The
African Organization for Research and Training in
Cancer (AORTIC) is already working to take advantage
of ICTs for education and training. As part of the road-
map for cancer control in Africa, AORTIC’s Education
and Training (E&T) committee is building virtual infra-
structure and resources that will benefit e-health in
E&T. This will follow a short survey to better assess
the existing workforce, educational pathways, and
needs and access to ICTs. Results will be presented at
the AORTIC 2015 conference in Morocco. An AORTIC
virtual education platform will facilitate access to continu-
ous education modules and other programmes that could
significantly help build capacity for clinical oncology in
Africa. If well-coordinated, the growing use of ICTS via
these models could significantly impact e-health for clin-
ical oncology in Africa, and AORTIC members are par-
ticularly encouraged to take advantage and let others
know about these emerging opportunities.
An overview of cancer situation in Africa
The second day started with an overview of the cancer
situation in Africa, diagnostic and treatment facilities, as
well as an overview of paediatric oncology in Africa and
cost-effective treatments. The presentation was given by
Cristina Stefan, AORTIC vice-president, Southern
Africa. She described how starting with the end in mind
allows us to develop plans for each East African country,
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and develop strategies for implementation and common
principles in controlling cancer on the continent.
In Africa, projections have indicated that deaths from
NCDs will exceed all combined communicable, mater-
nal, perinatal and nutritional diseases as the most com-
mon causes of death by 2030.
There are 19 million new cases of cancer predicted by
2025, with a remarkable increase in low- to middle-
income countries. The growth of cancer incidence on
the African continent is considerable when viewed in
the context of a century of a double or triple burden dis-
ease, with cancer now representing a real developmental
problem. The survival of people with cancer in Africa is
far behind the figures in high-income countries. For ex-
ample, the 5-year survival ratio of women with breast
cancer [2] in Europe is 82 %, in Uganda it is 46 %, 39 %
in Algeria and in Gambia it is only 12 %.
Africa is experiencing a unique health trajectory with
huge differentials between African countries on basic
spend budget for health.
Africa’s burden is uncertain, but whatever the ‘real’
numbers are, cancer cases and other NCDs are going to
be a major burden. Population increase, increased life
span and modifiable risk factor exposure are all contrib-
uting factors. It is not yet known how HIV/AIDS will
change the burden of NCDs. In this context, prevention
remains essential even if it is translated in very high
costs.
Africa is moving in the right direction to acknowledge
the present impact and future burden of cancer on the
continent. The correct strategies for faster implementa-
tion are required, as are sustainable and viable solutions.
At the end of her presentation, Dr Stefan proposed
some innovative ideas such as a case for a global cancer
fund, expanding the Bugando model to eastern Africa,
telepathology and a consideration for an African path-
ology school.
Strategies for improving oncologic care in East Africa
The second presenter of the day was Nicholas Othieno-
Abinya, the secretary-elect of AORTIC.
Africa is the second largest continent, with a popula-
tion of 1.1 billion people, second only to Asia. It argu-
ably has the highest concentration of natural resources,
but it is also the most resource-challenged continent.
About 800 000 new cancer cases occur in 2012 and the
figure is to be closer to 1.4 million annually within the
next two decades [3]. Breast cancer and cervical cancers
are on the top of the list for women while prostate and
lung account for the vast majority in males. These num-
bers are expected to double by 2030, mainly because of
the increased age of a growing population. The majority
of patients are diagnosed late, diagnosis is largely in-
accurate, and survival rates are much lower than in any
other continent. Malaria, tuberculosis, amoebiasis, ty-
phoid and brucellosis are often diagnosed at the expense
of other conditions, including cancer, until it is too late.
Most cancers are treated by herbalists and charlatans
masquerading as ‘professors’ of one discipline or another.
The few available experts engage in individual, unregulated
practices. Costly and toxic curative treatments are offered
to terminal patients, while half-hearted treatments are
offered to those requiring intensive, curative approaches.
The lack of diagnostic personnel and equipment hampers
conclusive diagnosis. National cancer control programmes
are mainly nonexistent and political expediency drives all
policy. Even well-trained personnel resort to outdated
shortcuts as a ‘something is better than nothing’ mentality
prevails.
Inequitable distribution of facilities and services leave
the great majority of the population to their own fates.
Many cancers have known modifiable risk factors, if not
causes, yet the will to face the challenge for their control
is lacking.
A number of solutions were proposed, which included
the improvement of economies, accelerated training of
pathology personnel, enhancement of cancer diagnosis
and treatment infrastructure, and intensification of early
detection and prevention strategies, amongst the others.
A pilot curriculum for the implementation of 3D-CRT
Dr Oniyinye D Balogun talked about radiation therapy
centers in developing countries that are beginning to
adopt 3D-CRT. Standardised instruments for assisting
RT professionals as they transition from 2D to 3D-CRT
planning are lacking. Funded by a peer-reviewed depart-
mental grant, we pilot-tested a 2-week curriculum for
implementing 3D-CRT for breast cancer, designed to
provide the basic foundations for RT professionals. An
additional aim of the project was to assess feasibility to
use this as a model for wider application in other
centers.
The presenter described a pilot site, the National Center
of Oncology in Yerevan, Armenia, which acquired a CT
simulator and linear accelerator in 2014. The training cur-
riculum for radiation oncologists (ROs), therapists (RTTs)
and medical physicists (MPs) of this pilot study consisted
of two intensive weeks, which included, inter alia, lectures
on the differences between 2D & 3D-CRT and 3D-CRT
benefits, lectures on prone positioning, review of the
RTOG Breast Cancer Atlas, practical training in supine
and prone CT simulation, and feedback from participants
using focus groups and questionnaires.
Ten RT professionals participated in the pilot curricu-
lum (six ROs, two MPs and two RTTs) and the assessment
demonstrated that contouring was widely considered the
most useful aspect of the curriculum. The key challenges
included achieving individual participation in all aspects of
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the curriculum in a high-volume department (~100
patients/day with three machines) and limited use of the
CT simulator, and hence, CT simulation practice due to
the cost associated with its use.
In conclusions, a pilot curriculum to guide 3D-CRT
transition is feasible. It requires the availability of a team
of RT professionals from both collaborating institutions
and sufficient flexibility from all parties. It presents a
unique opportunity for an exchange of expertise. Based
on the initial success, this intervention has the potential
to benefit other developing countries and should be
adapted to the needs of each centre.
Oncology training and capacity building
Training in clinical oncology, building up capacity,
translational research and challenges in eastern Africa
were discussed by a group of panelist chaired by F
Asirwa.
Training in traslational research: opportunities and
challenges in East Africa
DINO AMADORI, the brain and energy behind the
Mwanza project and Bugando medical centre, empha-
sised that translational research remains today the most
relevant field of preclinical and clinical research in on-
cology. Basic research allows us to understand the fun-
damental aspects of phenomena (cancer disease in our
interest). This knowledge then has to be used (through
clinical trials) to produce new drugs, devices and treat-
ment options for patients.
Precision medicine includes treatments targeted to the
needs of individual patients on the basis of genetics, bio-
markers, and phenotypic or psychosocial characteristics
during all stages of care, including prevention, diagnosis,
treatment and follow-up. The goal is to improve clinical
outcomes for individual patients by minimising unneces-
sary side effects. Individual patients have specific needs,
which are the result of their genetic makeup and expos-
ure to environmental risk factors. Health systems have
to provide diagnostics, informatics and decision-making
support to health care providers.
As more progress is made each day in oncology, a per-
sonalised treatment with the tailoring of cancer treat-
ments to individual characteristics will be the next step.
The role of biobanking in cancer research
One of the last presentations highlighted the role of bio-
banking in joint African collaborations, and was given
by Maimuna Mendy from IARC. This topic was followed
by the role of government and ministries of health in
advocacy and maintaining the quality of pathology
services.
The biobank presentation introduced key principles of
biobanking, its relevance in cancer research and ethics,
legal and issues (ELSI) that should be taking into ac-
count from recruitment, sample acquisition, storage
use and re-use of samples. A biobank is defined as a
collection of biological material and their associated
data, and it is rapidly being recognised as an important
infrastructure for cancer research. As medicine evolves,
researchers are identifying increasing numbers of mo-
lecular analytes and biomarkers that characterise both
healthy and medical conditions.
However, due to limited resources and related con-
straints, biobank introduction in African health service
institutions is occurring at a slower pace compared to
non-African countries [4]. In addition, many African
countries are yet to develop standard guidelines and pro-
tocols regulating the collection, processing, storing and
sharing of biological samples for future unspecified use.
The established procedures and protocols we used in Af-
rica should be in line with international guidelines, while
also taking into account national and local norms.
The importance of biobanking in prospective studies
and linkage to cancer registries as a research platform
and to monitor cancer incidence, has been demonstrated
in the example of the Gambia Hepatitis Intervention
study-GHIS [5] The GHIS was initiated in 1992 with the
aim of determining the efficacy of HBV vaccination to
prevent infection and liver cancer. At the same time, the
national cancer registry was established in close collab-
oration with pathology services to record and monitor
cancer incidence, thus providing a reliable platform for
documenting the endpoint for the intervention study.
The GHIS benefited from the well-established biobank
in Gambia that stored, managed and provided the valu-
able biological samples and data for the vaccine efficacy
and follow-up studies [6].
With the cancer burden projected to increase by 70 %
over the next two decades in LMICs, including Africa,
and as the complexity of diseases also increases, largely
due to multifactorial risk factors including environmen-
tal and genetic factors, it is the right time for African in-
stitutions to establish infrastructures to ensure the
availability of African biological resources for multidis-
ciplinary research in order to contribute to cancer
control and public health.
Summary of the meeting and the plan of action
A number of solutions were proposed, which included
along the improvement of economies, accelerated train-
ing of pathology personnel, enhancement of cancer diag-
nosis and treatment infrastructure and intensification of
early detection and prevention strategies. Other more in-
novative ideas included a case for a global cancer fund,
telepathology and a consideration for an African path-
ology school.
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Expanding the success of the Bugando model could be
translated in sharing its lessons more widely through sci-
entific presentations and hosting further training session.
The participants have agreed to set up four commit-
tees with the mandate to develop in short term the ac-
tion plan in the domain of Clinical oncology, Pathology,
Telemedicine/Telepathology and Research. The commit-
tees will work in collaboration with the existing commit-
tees in AORTIC and plan a follow up meeting next year
in Eastern Africa.
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